Change template to: full
Regular articles
Chemotherapy in the elderly – How intense should treatment be?
Axel R. Zander1, René J. Hornung2, Hans-Peter Lipp3
Allogeneic hematopoietic stem cell transplantation and solid organ transplantation in the same patient
Tapani Ruutu1, Christian Koenecke2 and Grzegorz W. Basak3
MRD evaluation, targeted therapy and stem cell transplantation: how to combine in adult ALL
Dieter Hoelzer
Saint-Petersburg experience of allogeneic hematopoietic stem cell transplantation in patients with acute leukemia and human immunodeficiency virus
Boris V. Afanasyev1, Marina Popova1, Sergey Bondarenko1, Ilya Zyuzgin2, Elena Babenko1, Aleksander Alyanskiy1, Susanne Morsch3, Jan van Lunzen4, Boris Fehse5, Axel R. Zander 5, Ludmila S. Zubarovskaya1
Should Allogeneic Hematopoietic Stem Cell Transplantation be a Treatment Option for Patients with Nijmegen Breakage Syndrome? Belarusian Experience
Olga V. Aleinikova, Alina S. Fedorova, Svetlana O. Sharapova
Prognostic significance of vascular endothelial growth factor and circulating endothelial cells for early and late outcomes of allogeneic hematopoietic stem cell transplantation
Ivan S. Moiseev, Sergej V. Lapin, Elena A. Surkova, Margarita Y. Lerner, Elena V. Babenko, Alexandra A. Sipol,
Vladimir N. Vavilov, Boris V. Afanasyev
Comparative effects of intramyocardial autotransplantation of different bone marrow cells upon outcomes of experimental myocardial infarction in rabbits
Vladimir V. Davydenko1, Andrey A. Matyukov1, Timur D. Vlasov1, Natalya V. Tsupkina2, Anatoly N. Yalfimov3,
Georgy P. Pinaev2, Khalida K. Amineva1